140 related articles for article (PubMed ID: 22658215)
1. Metabolic imaging biomarkers of postradiotherapy xerostomia.
Cannon B; Schwartz DL; Dong L
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1609-16. PubMed ID: 22658215
[TBL] [Abstract][Full Text] [Related]
2. Mid-treatment 18F-FDG PET imaging changes in parotid gland correlates to radiation-induced xerostomia.
Trada Y; Lee MT; Jameson MG; Chlap P; Keall P; Moses D; Lin P; Fowler A
Radiother Oncol; 2023 Sep; 186():109745. PubMed ID: 37330056
[TBL] [Abstract][Full Text] [Related]
3. FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
Roach MC; Turkington TG; Higgins KA; Hawk TC; Hoang JK; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):321-6. PubMed ID: 21030160
[TBL] [Abstract][Full Text] [Related]
4.
van Dijk LV; Noordzij W; Brouwer CL; Boellaard R; Burgerhof JGM; Langendijk JA; Sijtsema NM; Steenbakkers RJHM
Radiother Oncol; 2018 Jan; 126(1):89-95. PubMed ID: 28951007
[TBL] [Abstract][Full Text] [Related]
5. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
6. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
Acad Radiol; 2014 Oct; 21(10):1304-13. PubMed ID: 25088832
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
Münter MW; Karger CP; Hoffner SG; Hof H; Thilmann C; Rudat V; Nill S; Wannenmacher M; Debus J
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):175-84. PubMed ID: 14697436
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
Chao KS; Deasy JO; Markman J; Haynie J; Perez CA; Purdy JA; Low DA
Int J Radiat Oncol Biol Phys; 2001 Mar; 49(4):907-16. PubMed ID: 11240231
[TBL] [Abstract][Full Text] [Related]
10. A Deep Learning Model for Predicting Xerostomia Due to Radiation Therapy for Head and Neck Squamous Cell Carcinoma in the RTOG 0522 Clinical Trial.
Men K; Geng H; Zhong H; Fan Y; Lin A; Xiao Y
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):440-447. PubMed ID: 31201897
[TBL] [Abstract][Full Text] [Related]
11. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
[TBL] [Abstract][Full Text] [Related]
12.
Elhalawani H; Cardenas CE; Volpe S; Barua S; Stieb S; Rock CB; Lin T; Yang P; Wu H; Zaveri J; Elgohari B; Abdallah LE; Jethanandani A; Mohamed ASR; Court LE; Hutcheson KA; Brandon Gunn G; Rosenthal DI; Frank SJ; Garden AS; Rao A; Fuller CD
Clin Transl Radiat Oncol; 2021 Jul; 29():93-101. PubMed ID: 34195391
[TBL] [Abstract][Full Text] [Related]
13. Validation of the
Li Y; Sijtsema NM; de Vette SPM; Steenbakkers RJHM; Zhang F; Noordzij W; Van den Bosch L; Langendijk JA; van Dijk LV
Radiother Oncol; 2023 Mar; 180():109458. PubMed ID: 36608769
[TBL] [Abstract][Full Text] [Related]
14. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.
Henson BS; Inglehart MR; Eisbruch A; Ship JA
Oral Oncol; 2001 Jan; 37(1):84-93. PubMed ID: 11120488
[TBL] [Abstract][Full Text] [Related]
15. Single-Center Prospective Trial Investigating the Feasibility of Serial FDG-PET Guided Adaptive Radiation Therapy for Head and Neck Cancer.
Gouw ZAR; La Fontaine MD; Vogel WV; van de Kamer JB; Sonke JJ; Al-Mamgani A
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):960-968. PubMed ID: 32361007
[TBL] [Abstract][Full Text] [Related]
16. Early prediction of radiotherapy-induced parotid shrinkage and toxicity based on CT radiomics and fuzzy classification.
Pota M; Scalco E; Sanguineti G; Farneti A; Cattaneo GM; Rizzo G; Esposito M
Artif Intell Med; 2017 Sep; 81():41-53. PubMed ID: 28325604
[TBL] [Abstract][Full Text] [Related]
17. Is there a clinical benefit to adaptive planning during tomotherapy in patients with head and neck cancer at risk for xerostomia?
You SH; Kim SY; Lee CG; Keum KC; Kim JH; Lee IJ; Kim YB; Koom WS; Cho J; Kim SK; Kim GE
Am J Clin Oncol; 2012 Jun; 35(3):261-6. PubMed ID: 21383607
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract][Full Text] [Related]
19. Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study.
Burlage FR; Roesink JM; Kampinga HH; Coppes RP; Terhaard C; Langendijk JA; van Luijk P; Stokman MA; Vissink A
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):14-22. PubMed ID: 17869018
[TBL] [Abstract][Full Text] [Related]
20. Comparison of xerostomia incidence after three-dimensional conformal radiation therapy and contralateral superficial lobe parotid-sparing intensity-modulated radiotherapy for oropharyngeal and hypopharyngeal cancer.
Kawamoto T; Nihei K; Nakajima Y; Kito S; Sasai K; Karasawa K
Auris Nasus Larynx; 2018 Oct; 45(5):1073-1079. PubMed ID: 29397249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
